Cefuroxime + Clavulanic Acid

Combinations of Cefuroxime and Clavulanic Acid

  • Cefuroxime 500mg & Clavulanic Acid 125 mg. Tablets
  • Cefuroxime 250 mg & Clavulanic Acid 62.5 mg. Tablets
  • Cefuroxime 125 mg & & Clavulanic Acid 31.25 mg. Tablets
  • Cefuroxime 125 mg & & Clavulanic Acid 31.25 mg. per 5 ml Dry Syrup

Cefuroxime and Clavulanic Acid: A combination of cefuroxime and ß -lactamase inhibitor (Clavulanic acid) for the treatment of various bacterial infections

EXECUTIVE SUMMARY
Drug Name Cefuroxime+ Clavulanic Acid
Mechanism of Action

CEFUROXIME: Bactericidal action due to inhibition of cell-wall synthesis.

Clavulanic Acid: Enzyme inhibitor that enhances the antibacterial activity
Indication CEFUROXIME-CLAV is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below:
  • Pharyngitis/tonsillitis
  • Acute bacterial otitis media
  • Acute bacterial maxillary sinusitis
  • Acute bacterial exacerbations of chronic bronchitis and secondary bacterial infections of acute bronchitis
  • Uncomplicated skin and skin-structure infections
  • Uncomplicated urinary tract infections
  • Uncomplicated gonorrhea (urethral and endocervical)
  • Early lyme disease (erythema migrans)
Form

Tablets (Cefuroxime/Clavulanic Acid) : 500/125mg 250/62.5mg, 125/31.25mg

Dry Syrup(Cefuroxime/Clavulanic Acid) : 125/31.25mg